Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Oncology

Modern radiation therapy and treatment of cancer

There were about 200,000 new cases of cancer in Thailand in 2020. Recent advances in the fields of surgical oncology, medical oncology, and radiation oncology have immensely improved the results of cancer treatment. Even with the best multidisciplinary treatment, in more than half of the patients, cancer will recur and…

Bangkok Post

Kura Oncology Stock Shows Improved Relative Strength; Still Shy Of Benchmark

Kura Oncology shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Aveo Stock Continues Its Bullish Run After Snagging $566 Million LG Chem Buyout

Aveo Oncology agreed to be acquired by Korea's LG Chem on Tuesday, and Aveo stock skyrocketed to a near two-year high on the news.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Child cancer survivor qualifies as paediatric nurse with oncology aims to help kids through same disease

The 22-year-old says she promised herself two things - that she would win her fight and that she would one day help care for children in the way that she was cared for

Irish Mirror

Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga

Queensland nurse becomes state’s first oncology carer after beating her own cancer

Nicole Williams felt "angry" when a cancer diagnosis "interrupted" her studies, but she fought through it to become the state's only nurse practitioner for general oncology and now helps others fight their own battles.

ABC News

Read news from The Economist, FT, and more,
with one subscription

ALLR: A Precision Undertaking

By John Vandermosten, CFA NASDAQ:ALLR READ THE FULL ALLR RESEARCH REPORT

Benzinga

Patients moved from Monklands Hospital after potentially deadly fungus found

NHS Lanarkshire say precautionary measures are being taken and no patient is currently displaying signs of illness.

Daily Record

3 Falling Stock to Think About Selling Short Right Now

Worries about sky-high inflation, the Federal Reserve’s hawkish stance, and recession prospects have spurred market sell-off lately. Moreover, investors expect increased market volatility as analysts cut down their earnings estimates. Given the uncertain market conditions, fundamentally weak and losing stocks Snap (SNAP), Allegiant Travel (ALGT), and Cardiff Oncology (CRDF) could…

StockNews.com

Family warn parents to look out for 'obvious spots' after boy, 5, diagnosed with brain tumour

Their 5 year old is going through chemotherapy and his vision will be affected for the rest of his life

Nottingham Post

New womb cancer test could cut diagnosis time and reduce need for procedures

New research published in the Journal of Clinical Oncology has found that low-cost PCR test that took samples from the cervix or vagina successfully detected womb cancer.

Edinburgh Live

Tech & Science Daily: Womb cancer 2023 test breakthrough ‘cuts diagnosis time’

Tech & Science Daily meets first author Dr Chiara Herzog, researcher at Innsbruck’s European Translational Oncology Prevention and Screening Institute, on the new treatment.

Evening Standard

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug Application (NDA) for elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer. The agency has granted Priority Review designation and assigned a target action date of February 17, 2023. Radius Health…

The Hindu

Thiruvananthapuram to host global oncology conclave from Saturday

Thiruvananthapuram

Benzinga

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

The Canberra Times

'Great relief': ACT govt signals intention to gynaecology oncology unit

Canberra Health Services has advertised for a gynaecological oncologist.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Kura Oncology Stock Joins Rank Of Stocks With RS Ratings Over 90

Kura Oncology shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

The Conversation

Physician heal thyself? After 4 years of treatment for stage 4 cancer I just wanted some encouraging words from my oncologist

My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement, “Trust Your Instincts”. One day, bored with the long purgatory of the waiting room, I tweet this news to the world with the observation: “If I trusted my instincts, I’d run…

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Benzinga

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.

The Hindu

July 30 — Remembering the Founder of the Cancer Institute (WIA), Dr. Muthulakshmi Reddy

Dr. Muthulakshmi Reddy made several appeals to set up a specialized cancer centre in the city of Madras.

The Hindu

Coimbatore oncologist launches a digital flip book to create tobacco awareness

A 15-page digital flip book launched as a part of an ongoing monthly campaign urges people to quit tobacco for their own health and the health of the environment

1 … 4 5 6 7

People

Conor McGregor

4,120 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Canberra Health Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.